Condition
    Effectiveness 2/5

    Vitamin D for Vitiligo

    Vitamin D deficiency is more common in vitiligo, and small studies suggest correcting it may modestly support repigmentation when combined with phototherapy. It's an adjunct to dermatologist-led treatment, not a standalone fix.

    Overview

    Vitamin D deficiency is more common in vitiligo, and small studies suggest correcting it may modestly support repigmentation when combined with phototherapy. It's an adjunct to dermatologist-led treatment, not a standalone fix.

    Verdict

    Mixed evidence

    How It Works

    Vitamin D modulates the autoimmune activity that attacks melanocytes and may support melanocyte survival and pigment production, complementing narrowband UVB phototherapy.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1000-2000 IU (25-50 mcg) vitamin D3 daily with a fat-containing meal, as an adjunct to dermatological treatment
    Expected timeframe
    3-6 months if there is any response

    Protocol

    form
    Vitamin D3 (cholecalciferol) orally; topical vitamin D analogues such as calcipotriol are a separate, prescribed treatment used with steroids or phototherapy
    duration
    6 months with photographs at baseline and end
    co factor
    Take with the largest meal. Evidence is mixed and thin: low vitamin D is more common in vitiligo, which frequently coexists with autoimmune thyroid disease, and small uncontrolled series report repigmentation with high-dose vitamin D. Topical calcipotriol combined with narrowband UVB or topical steroids has better support than oral supplementation, which has no randomised evidence for repigmentation.
    titration
    Target 75-125 nmol/L. Small uncontrolled studies used high oral doses of 35,000 IU/day under close monitoring - this is not a self-directed regimen
    starting dose
    1000-2000 IU vitamin D3 daily with the largest meal, after checking 25-hydroxyvitamin D

    Evidence

    What the studies say

    Observational studies link low vitamin D to vitiligo, and a few small trials of oral vitamin D alongside phototherapy show better repigmentation than phototherapy alone. Effect sizes are modest and studies small; dermatology treatments (topicals, phototherapy, JAK inhibitors) remain primary.

    No studies are yet linked to both Vitamin D and Vitiligo.

    Safety

    Caveats

    Vitiligo needs dermatology input: narrowband UVB, topical calcineurin inhibitors, topical steroids and JAK inhibitors have real evidence, and early treatment gives better repigmentation. Depigmented skin burns easily and needs high-factor sun protection. Screen for associated autoimmune thyroid disease. Safety ceiling: the tolerable upper intake level is 4000 IU (100 mcg) per day; the very high doses in uncontrolled vitiligo reports carry a real risk of hypercalcaemia, kidney stones and kidney injury and must not be self-administered. Avoid unsupervised use in sarcoidosis, granulomatous disease and primary hyperparathyroidism. Interacts with thiazide diuretics and digoxin. Safe in pregnancy at 400-1000 IU/day.

    Less likely to help if

    People with normal vitamin D levels, and those with long-standing stable depigmentation on non-hairy sites, which repigments poorly with any treatment.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.